|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| C07K 16/241 | (2013.01) | ||
| C07K2317/41 | (2013.01) | ||
| C07K2317/524 | (2013.01) | ||
| C07K2317/526 | (2013.01) | ||
| C07K2317/72 | (2013.01) | ||
| C07K2317/732 | (2013.01) | ||
| C07K2317/734 | (2013.01) | ||
| C07K2317/74 | (2013.01) | ||
| C07K2317/77 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K2317/76 | (2013.01) |
| (11) | Number of the document | 3456737 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17191988.9 |
| Date of filing the European patent application | 2017-09-19 | |
| (97) | Date of publication of the European application | 2019-03-20 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-14 |
| (46) | Date of publication of the claims translation |
| (72) |
FURRER, Esther , CH
|
| (73) |
TILLOTTS PHARMA AG ,
Baslerstrasse 15, 4310 Rheinfelden,
CH
|
| (54) | ANTIBODY VARIANTS |
| ANTIBODY VARIANTS |